期刊文献+

发挥优势 开拓创新——试析循证医学中的内分泌临床试验

Take advantage of our clinical resources and make new exploration--Introduction of endocrine clinical trial in evidence-based medicine
原文传递
导出
摘要 循证医学具有完整的临床试验体系,有系统综述和荟萃分析,其中随机、对照、双盲的临床试验在循证医学中处于核心地位。发挥我国临床试验的优势,积极参与国际临床合作研究。 Evidence-based medicine has a complete system of clinical trial including systematic reviews and meta-analysis, among them randomized controlled double-blind clinical trial plays a key role in evidence-based medicine. Taking our advantage in clinical trial, we should actively participate in international clinical collaborative studies.
作者 潘长玉
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2007年第1期1-4,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 临床试验 循证医学 Clinical trials Evedence-based medicine
  • 相关文献

参考文献17

  • 1Evidence-based medicine working group.Evidence-based medicine.A new approach to teaching the practice of medicine.JAMA,1992,268:2420-2425.
  • 2The WHO.International Clinical Trial Registry Platform (ICTRP),Frequently Asked Questions.Available from http://www.who.int/entity/ictrp/faq/en/index.html
  • 3The Medical Research Library of Brooklyn.http://servers.medlib.hscbklyn.edu/ebm/2100.htm
  • 4Chiasson JL,Josse RG,Gomis R,et al.Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance:the STOP-NIDDM trial.JAMA,2003,290:486-494.
  • 5Colhoun HM,Betteridge DJ,Durrington PN,et al.Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):Multicentre randomised placebo-controlled trial.Lancet,2004,354:685-696.
  • 6Knopp RH,D'Emden M,Smilde JG,et al.Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes:the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Depedent Diabetes Mellitus (ASPEN).Diabetes Care,2006,29:1478-1485.
  • 7Cholesterol Treatment Trialists,(CTT) Collaborators.Efficacy and safety of cholesterol-lowering treatment:Prospective Meta-analysis of data from 90 056 patients in 14 randomised trials of statins.Lancet,2005,366:1267-1278.
  • 8Keech A,Simes RJ,Barter P,et al.Effect of long-term therapy on cardiovascular events in 9 795 people with type 2 diabetes mellitus (the FIELD Study) randomised controlled trial.Lancet,2005,366:1849-1861.
  • 9The DREAM (Disease Reduction Assessment with Remipril and Rosiglitazone Medication) trial investigetors.Effect of rosiglitazone on frequency of diabetes in patients with impaired glucose tolerance and impaired fasting glucose:A randomised controlled trial.Lancet,2006,368:1096-1105.
  • 10Kahn SE,Haffner SM,Heise MA,et al.for the ADOPT Study Group.Glycemic durability of rosiglitazone,metformin,or glyburide monotherapy.N Engl J Med,2006,355:2427-2443.

二级参考文献5

共引文献578

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部